Cancer

Items 151-160 of 184

per page
Set Descending Direction
  1. MOTS-c (human)
    CAS  1627580-64-6
    AG-CP3-0026
    AG-CP3-0026-M0011 mg
    CHF 180.00
    AG-CP3-0026-M0055 mg
    CHF 630.00
    MOTS-c (human)
  2. MOTS-c (K14Q Mutant) (human)
    AG-CP3-0033
    AG-CP3-0033-M0011 mg
    CHF 180.00
    AG-CP3-0033-M0055 mg
    CHF 630.00
    MOTS-c (K14Q Mutant) (human)
  3. NAD Kinase (human) (rec.) (His) (highly active)
    AG-40T-0091
    AG-40T-0091-C05050 µg
    CHF 470.00
  4. NF-κB (p50) (human) (rec.) (His) (highly active)
    AG-40T-0021
    AG-40T-0021-C0022 µg
    CHF 450.00
  5. NF-κB (p65) (human) (rec.) (His) (highly active)
    AG-40T-0020
    AG-40T-0020-C0022 µg
    CHF 390.00
  6. NMNAT1 (human) (rec.) (His) (highly active)
    AG-40T-0092
    AG-40T-0092-C01010 µg
    CHF 240.00
    AG-40T-0092-C05050 µg
    CHF 440.00
  7. NMNAT3 (human) (rec.) (His) (highly active)
    AG-40T-0093
    AG-40T-0093-C01010 µg
    CHF 260.00
    AG-40T-0093-C05050 µg
    CHF 600.00
  8. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  9. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us

Items 151-160 of 184

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.